abrdn Healthcare Opportunities Fund (NYSE: THQ) director buys 568 shares

Rhea-AI Filing Summary

abrdn Healthcare Opportunities Fund director Chris LaVictoire Mahai purchased 568 shares of Common Stock on July 16, 2026 at $18.49 per share, bringing direct holdings to 568 shares. The trade is reported as a purchase in an open market or private transaction and is not marked as pursuant to a Rule 10b5-1 trading plan.

Insider Trade Summary

Net Buyer: 568 shares

Net Buy 1 txn

Insider Mahai Chris LaVictoire

Role Director

Bought 568 shs ($11K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	568	$18.49	$11K

Holdings After Transaction: Common Stock — 568 shares (Direct)

Key Figures

Shares purchased: 568.0000 shares Purchase price: $18.4900 per share Shares owned after transaction: 568.0000 shares +1 more

4 metrics

Shares purchased 568.0000 shares Common Stock purchased on July 16, 2026

Purchase price $18.4900 per share Price paid per share for the 568.0000 shares

Shares owned after transaction 568.0000 shares Direct holdings following the reported purchase

Net shares bought 568 shares Net buy volume reported in transaction summary

Key Terms

Common Stock, open market or private transaction, Rule 10b5-1 trading plan

3 terms

Common Stock financial

"security_title is listed as Common Stock for this transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open market or private transaction financial

"transaction_code_description states Purchase in open market or private transaction"

Rule 10b5-1 trading plan regulatory

"The trade is not marked as pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/20/2026 - 02:31 PM Accepted by SEC EDGAR 07/20/2026 - 02:31 PM Learn about SEC filing dates

FAQ

What insider share purchase in THQ did Chris LaVictoire Mahai report?

Chris LaVictoire Mahai reported buying 568 shares of THQ Common Stock. The purchase occurred on July 16, 2026 and is classified as a purchase in an open market or private transaction, increasing direct ownership to 568 shares.

At what price were the THQ shares bought in this Form 4 transaction?

The THQ shares were bought at $18.49 per share. This per-share price applies to all 568 shares reported in the transaction, which is described as an open market or private purchase of Common Stock.

How many THQ shares does Chris LaVictoire Mahai own after this transaction?

After the reported trade, Chris LaVictoire Mahai directly owns 568 THQ shares. All currently reported holdings come from this single Common Stock purchase on July 16, 2026, according to the post-transaction ownership figure disclosed.

Was the THQ insider trade by Chris LaVictoire Mahai under a Rule 10b5-1 plan?

No, the trade is not marked as pursuant to a Rule 10b5-1 plan. The Rule 10b5-1 checkbox is left unchecked, indicating the transaction was not executed under a pre-arranged trading plan framework.

What type of security did THQ director Chris LaVictoire Mahai purchase?

Chris LaVictoire Mahai purchased Common Stock of abrdn Healthcare Opportunities Fund (THQ). The Form 4 identifies the security as Common Stock, with 568 shares acquired in a single open market or private transaction at $18.49 per share.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mahai Chris LaVictoire

(Last) (First) (Middle)

C/O ABRDN

1900 MARKET STREET, SUITE 200

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
abrdn Healthcare Opportunities Fund [ THQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/16/2026		P		568	A	$18.49	568	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Robert Stieger, by POA from Reporting Person	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)